Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:disease
|
gptkbp:abbreviation |
gptkb:Type_2_diabetes_mellitus
|
gptkbp:affects |
humans
|
gptkbp:alsoKnownAs |
adult-onset diabetes
non-insulin-dependent diabetes mellitus |
gptkbp:associatedWith |
gptkb:metabolic_syndrome
hypertension dyslipidemia hyperglycemia |
gptkbp:canBeChronic |
yes
|
gptkbp:characterizedBy |
insulin resistance
relative insulin deficiency |
gptkbp:complication |
gptkb:cardiovascular_disease
stroke kidney failure nerve damage retinopathy foot ulcers |
gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting blood glucose |
gptkbp:firstDescribed |
20th century
|
gptkbp:fullName |
gptkb:Type_2_diabetes_mellitus
|
gptkbp:hasGeneticComponent |
yes
|
https://www.w3.org/2000/01/rdf-schema#label |
T2DM
|
gptkbp:ICD-10_code |
E11
|
gptkbp:isNonCommunicable |
yes
|
gptkbp:managedBy |
endocrinologist
primary care physician |
gptkbp:onset |
adulthood
|
gptkbp:prevalence |
high worldwide
|
gptkbp:prevention |
healthy diet
maintaining normal body weight regular physical activity avoiding tobacco use |
gptkbp:riskFactor |
obesity
physical inactivity older age family history of diabetes unhealthy diet |
gptkbp:symptom |
fatigue
blurred vision frequent urination increased thirst increased hunger |
gptkbp:treatment |
lifestyle modification
oral hypoglycemic agents insulin therapy |
gptkbp:bfsParent |
gptkb:Type_2_Diabetes
gptkb:diabetes_mellitus_type_2 |
gptkbp:bfsLayer |
7
|